Dilated Cardiomyopathy Pipeline includes novel therapies such as Ixmyelocel-T (Vericel), PF-07265803 /ARRY-3717 97 (Pfizer), CAP-1002 (Capricor Therapeutics), MYK-491 (MyoKardia), Ifetroban (Cumberland Pharmaceuticals), and BC 007 (Berlin Cures) that are anticipated to shift the Dilated Cardiomyopathy Market landscape positively.